| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
BioCardia Inc (NASDAQ: BCDA)
BCDA Technical Analysis
4
| As on 13th Jun 2025 BCDA STOCK Price closed @ 2.18 and we RECOMMEND Buy for LONG-TERM with Stoploss of 1.74 & Strong Buy for SHORT-TERM with Stoploss of 0.51 we also expect STOCK to react on Following IMPORTANT LEVELS. |
BCDASTOCK Price
| Open | 2.17 | Change | Price | % |
| High | 2.24 | 1 Day | -0.02 | -0.91 |
| Low | 2.14 | 1 Week | 0.01 | 0.46 |
| Close | 2.18 | 1 Month | -0.67 | -23.51 |
| Volume | 12792 | 1 Year | 1.53 | 235.38 |
| 52 Week High 5.20 | 52 Week Low 0.31 | ||||
NASDAQ USA Most Active Stocks
| HCTI | 0.02 | -33.33% |
| GNLN | 0.01 | -50.00% |
| AMRS | 0.14 | 100.00% |
| NVDA | 141.97 | -2.09% |
| TSLA | 325.31 | 1.94% |
| LMDX | 0.02 | 0.00% |
| NCNA | 0.11 | -26.67% |
| USEG | 2.21 | 55.63% |
| AKTS | 0.04 | 0.00% |
| LCID | 2.10 | -2.78% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| BCDA Daily Charts |
BCDA Intraday Charts |
Whats New @ Bazaartrend |
BCDA Free Analysis |
|
|
BCDA Important Levels Intraday
| RESISTANCE | 2.37 |
| RESISTANCE | 2.31 |
| RESISTANCE | 2.27 |
| RESISTANCE | 2.23 |
| SUPPORT | 2.13 |
| SUPPORT | 2.09 |
| SUPPORT | 2.05 |
| SUPPORT | 1.99 |
BCDA Forecast June 2025
| 4th UP Forecast | 2.74 |
| 3rd UP Forecast | 2.56 |
| 2nd UP Forecast | 2.45 |
| 1st UP Forecast | 2.34 |
| 1st DOWN Forecast | 2.02 |
| 2nd DOWN Forecast | 1.91 |
| 3rd DOWN Forecast | 1.8 |
| 4th DOWN Forecast | 1.62 |
BCDA Weekly Forecast
| 4th UP Forecast | 2.37 |
| 3rd UP Forecast | 2.31 |
| 2nd UP Forecast | 2.27 |
| 1st UP Forecast | 2.23 |
| 1st DOWN Forecast | 2.13 |
| 2nd DOWN Forecast | 2.09 |
| 3rd DOWN Forecast | 2.05 |
| 4th DOWN Forecast | 1.99 |
BCDA Forecast2025
| 4th UP Forecast | 12.57 |
| 3rd UP Forecast | 9.24 |
| 2nd UP Forecast | 7.18 |
| 1st UP Forecast | 5.12 |
| 1st DOWN Forecast | -0.76 |
| 2nd DOWN Forecast | -2.82 |
| 3rd DOWN Forecast | -4.88 |
| 4th DOWN Forecast | -8.21 |
BioCardia Inc ( NASDAQ USA Symbol : BCDA )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
BCDA Business Profile
BioCardia, Inc., a clinical-stage regenerative medicine company, develops therapeutics for cardiovascular diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia; and ALLOGENEIC cell therapy for cardiac and pulmonary disease. The company is also developing ALLOGENEIC Cell Therapy System, an investigational culture expanded bone marrow derived mesenchymal cell therapy, which is in Phase I/II trial for the treatment of ischemic systolic heart failure. In addition, it offers the Helix biotherapeutic delivery system, a percutaneous catheter delivery system for cardiovascular regenerative medicine; and Morph deflectable guides and sheaths. The company is based in San Carlos, California. Address: 125 Shoreway Road, San Carlos, CA, United States, 94070
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service